MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack

MacroGenics has announced the sale of its manufacturing operations for $122.5 million, marking a significant shift in its business strategy. Meanwhile, West Pharma has disclosed a cybersecurity attack, raising concerns about data security in the biotech sector. Additionally, Bavarian Nordic and OrganaBio are launching a new CDMO subsidiary, indicating ongoing developments in contract manufacturing within the industry.